Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Dow
Mallinckrodt
Express Scripts
Daiichi Sankyo
Johnson and Johnson
Teva
Moodys
McKesson

Generated: May 21, 2018

DrugPatentWatch Database Preview

PENAPAR-VK Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Penapar-vk patents expire, and what generic alternatives are available?

Penapar-vk is a drug marketed by Parke Davis and is included in two NDAs.

The generic ingredient in PENAPAR-VK is penicillin v potassium. There are ninety drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the penicillin v potassium profile page.
Summary for PENAPAR-VK
Drug patent expirations by year for PENAPAR-VK
Synonyms for PENAPAR-VK
(2S,5R,6R)-3,3-DIMETHYL-7-OXO-6-(2-PHENOXYACETAMIDO)-4-THIA-1- AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID
(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(2-phenoxyacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(2-phenoxyacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-7-oxo-6-{[(phenyloxy)acetyl]amino}-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
1098-87-9 (mono-hydrochloride salt)
132-98-9
132-98-9 (mono-potassium salt)
147-48-8 (mono-hydrochloride salt)
2,2-dimethyl-6beta-[(phenoxyacetyl)amino]penam-3alpha-carbonyl
2,2-dimethyl-6beta-[(phenoxyacetyl)amino]penam-3alpha-carboxylic acid
3,3-dimethyl-6beta-[(phenoxyacetyl)amino]penam-2alpha-carboxylic acid (PIN)
3,3-Dimethyl-7-oxo-6-((phenyloxyacetyl)amino)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
4-27-00-05884 (Beilstein Handbook Reference)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenoxyacetyl)amino)-, (2S-(2alpha,5alpha,6beta))-
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenoxyacetamido)-
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-, (2S,5R,6R)-
6-Phenoxyacetamidopenicillanic acid
6beta-Phenoxyacetamido-2,2-dimethylpenam-3alpha-carboxylic acid
87-08-1
AB00514745
AC1L1NHG
AC1Q5QX3
Acipen V
acipen-v
AK322414
AKOS015969737
Apocillin
Apopen
BDBM50370584
Beepen-VK
Beromycin
Beromycin, Penicillin
Berromycin, Penicillin
Betapen-VK
Bio-0630
BPLBGHOLXOTWMN-MBNYWOFBSA-N
BRD-K43966364-237-02-2
BRN 0096259
BSPBio_002185
C-53179
C08126
C16H18N2O5S
Calcipen
CCRIS 752
CHEBI:27446
CHEBI:53706
CHEMBL615
Compocillin V
Crystapen V
CTK3E8206
D05411
D09CPR
DB00417
Distaquaine V
DivK1c_000779
DTXSID3023429
EINECS 201-722-0
Epitope ID:115011
Epitope ID:116056
Eskacillian V
Eskacillin V
Fenacilin
Fenospen
Fenossimetilpenicillina
Fenossimetilpenicillina [DCIT]
Fenoximetilpenicilina
Fenoximetilpenicilina [INN-Spanish]
Fenoxymethylpenicillin
Fenoxypen
HE016571
HSDB 6314
IDI1_000779
KBio1_000779
KBio2_001487
KBio2_004055
KBio2_006623
KBio3_001685
KBioGR_000944
KBioSS_001487
LS-1861
Meropenin
MLS001304105
NINDS_000779
Oracillin
Oratren
Ospen
P-Mega-Tablinen
Pen-Oral
Pen-V
Pen-vee
Penicillanic acid, 6-phenoxyacetamido-
Penicillin phenoxymethyl
penicillin v
Penicillin V (USP)
Penicillin V [USAN:USP]
Penicillin V [USAN]
Penicillin V potassium
Penicillin V, United States Pharmacopeia (USP) Reference Standard
PENICILLIN VK
Penicillin-Vk
Penicillin, Phenoxymethyl
Phenocillin
Phenomycilline
Phenopenicillin
Phenoximethylpenicillinum
phenoxomethylpenicillanyl
phenoxomethylpenicillin
Phenoxymethyl penicillin
Phenoxymethylenepenicillinic acid
phenoxymethylpenicillanyl
Phenoxymethylpenicillin
Phenoxymethylpenicillin (INN)
Phenoxymethylpenicillin, Antibiotic for Culture Media Use Only
Phenoxymethylpenicillin, European Pharmacopoeia (EP) Reference Standard
Phenoxymethylpenicilline
Phenoxymethylpenicilline [INN-French]
phenoxymethylpenicillinic acid
Phenoxymethylpenicillinic acid potassium salt
Phenoxymethylpenicillinum
Phenoxymethylpenicillinum [INN-Latin]
PNV
Robicillin
Rocilin
SBI-0051477.P003
SCHEMBL49223
SMR000539431
SPBio_000389
Spectrum_001007
Spectrum2_000495
Spectrum3_000543
Spectrum4_000472
Spectrum5_001409
Stabicillin
UNII-Z61I075U2W
V-Cil
V-Cillin
V-Cillin (TN)
V-Cillin K
V-Cylina
V-Cyline
V-Tablopen
Vebecillin
Vegacillin
W-109316
Z61I075U2W
ZINC3831282

US Patents and Regulatory Information for PENAPAR-VK

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis PENAPAR-VK penicillin v potassium FOR SOLUTION;ORAL 062002-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Parke Davis PENAPAR-VK penicillin v potassium TABLET;ORAL 062001-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Parke Davis PENAPAR-VK penicillin v potassium FOR SOLUTION;ORAL 062002-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Parke Davis PENAPAR-VK penicillin v potassium TABLET;ORAL 062001-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Citi
Fuji
Teva
Argus Health
Covington
Queensland Health
Federal Trade Commission
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.